576 results on '"Pals, Steven T."'
Search Results
52. Additional file 1 of The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma
53. Syndecan-1 and stromal heparan sulfate proteoglycans: key moderators of plasma cell biology and myeloma pathogenesis
54. The small GTPase Ral mediates SDF-1–induced migration of B cells and multiple myeloma cells
55. Discriminating between Waldenström macroglobulinemia and marginal zone lymphoma using logistic LASSO regression.
56. A Bispecific Antibody Antagonizes Prosurvival CD40 Signaling and Promotes Vγ9Vδ2 T cell–Mediated Antitumor Responses in Human B-cell Malignancies
57. The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma
58. AKT signaling restrains tumor suppressive functions of FOXO transcription factors and GSK3 kinase in multiple myeloma
59. Illegitimate WNT signaling promotes proliferation of multiple myeloma cells
60. Heparan sulfate proteoglycans in the control of B cell development and the pathogenesis of multiple myeloma
61. Functional analysis of HGF/MET signaling and aberrant HGF-activator expression in diffuse large B-cell lymphoma
62. Expression of B-cell transcription factors in primary cutaneous B-cell lymphoma
63. Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation
64. Identification of the SRC-family tyrosine kinase HCK as a therapeutic target in mantle cell lymphoma
65. Towards genomic-based prognostication and precision therapy for diffuse large B-cell lymphoma
66. The Role of CD44 Splice Variants in Human Metastatic Cancer
67. Hyaluronic acid metabolism is increased in unstable plaques
68. Ixazomib, Rituximab and Dexamethasone (IRD) in Patients with Relapsed or Progressive Waldenstrom's Macroblobulinemia: Results of the Prospective Phase I/II HOVON 124/Ecwm-R2 Trial
69. High Frequencies of Mutated EZH2 and IRF8 and Other Epigenetic Genes in Primary Bone Lymphomas Are Indicative of GCB-Phenotype
70. MYD88 in the driver’s seat of B-cell lymphomagenesis: from molecular mechanisms to clinical implications
71. Targeting AKT elicits tumor suppressive functions of FOXO transcription factors and GSK3 kinase in Multiple Myeloma
72. Tissue-specific expression of IgG receptors by human macrophages ex vivo
73. MET Signaling Overcomes Epidermal Growth Factor Receptor Inhibition in Normal and Colorectal Cancer Stem Cells Causing Drug Resistance
74. Ixazomib, Rituximab and Dexamethasone (IRD) in Patients with Relapsed or Progressive Waldenstrom's Macroblobulinemia: Results of the Prospective Phase I/II HOVON 124/Ecwm-R2 Trial
75. Brutonʼs Tyrosine Kinase and Phospholipase Cγ2 Mediate Chemokine-Controlled B Cell Migration and Homing
76. Expression of CD44 splice variants in human primary brain tumors
77. High prevalence of the MYD88 L265P mutation in IgM anti-MAG paraprotein-associated peripheral neuropathy
78. Activation of Wnt signaling in the intestinal mucosa of Apc+/min mice does not cause overexpression of the receptor tyrosine kinase Met
79. CD44 Disruption Prevents Degeneration of the Capillary Network in Obstructive Nephropathy via Reduction of TGF-β1–Induced Apoptosis
80. The hepatocyte growth factor/ met pathway in development, tumorigenesis, and B-cell differentiation
81. CD44 Glycoproteins in Colorectal Cancer: Expression, Function, and Prognostic Value
82. CD44 Deficiency Increases Tubular Damage But Reduces Renal Fibrosis in Obstructive Nephropathy
83. CD44 is a macrophage binding site for Mycobacterium tuberculosis that mediates macrophage recruitment and protective immunity against tuberculosis
84. High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma
85. Immune responsiveness in renal transplant recipients: Mycophenolic acid severely depresses humoral immunity in vivo
86. Common variable immunodeficiency and hemophagocytic features associated with a FAS gene mutation
87. Regulation of Cytokine Signaling by B Cell Antigen Receptor and CD40-controlled Expression of Heparan Sulfate Proteoglycans
88. Relevance of CD44 Variant Epitopes for Diagnosis and Therapy of Human Breast Cancer
89. Aberrant expression and reverse signalling of CD70 on malignant B cells
90. Clinicopathological characteristics of T-NHL arising in patients with immunodeficiencies: a single-center case series of 25 patients and a review of the literature
91. MYD88 mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavorable prognosis
92. Human Fetal TNF-α-Cytokine-Producing CD4+ Effector Memory T Cells Promote Intestinal Development and Mediate Inflammation Early in Life
93. Frequent mutated B2M, EZH2, IRF8, and TNFRSF14in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype
94. Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarrays
95. CD44 Is Exposed to the Extracellular Matrix at Invasive Sites in Basal Cell Carcinomas
96. Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma
97. Paracrine Regulation of Germinal Center B Cell Adhesion through the c-Met-Hepatocyte Growth Factor/Scatter Factor Pathway
98. Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation.
99. Effect of CD44v6 on survival in colorectal carcinoma
100. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.